International Clinical Trial: Reduction of Elimination of Mitral Regurgitation With the SATURN TMVR System (CASSINI-US)

Geneva, Aug. 29 -- International Clinical Trials Registry received information related to the study (NCT07130994) titled 'Reduction of Elimination of Mitral Regurgitation With the SATURN TMVR System (CASSINI-US)' on Aug. 8.

Study Type: Interventional

Study Design: Allocation: N/A. Intervention model: Single Group Assignment. Primary purpose: Treatment. Masking: None (Open Label).

Primary Sponsor: InnovHeart

Condition: Mitral Regurgitation Heart Disease

Intervention: Device: Mitral Valve Replacement

Recruitment Status: Not recruiting

Phase: N/A

Date of First Enrollment: December 2025

Target Sample Size: 15

To know more, visit https://clinicaltrials.gov/ct2/show/NCT07130994

Published by HT Digital Content Services with per...